Related Experiment Videos
Treatment of coexisting diabetes and hypertension
1University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8899, USA.
Insights
Intensive treatment for patients with diabetes and hypertension is crucial to prevent cardiovascular complications. Combining lifestyle changes with multiple antihypertensive drugs, alongside managing blood sugar and cholesterol, is essential for optimal patient outcomes.
Area of Science:
- Cardiology
- Endocrinology
- Nephrology
Background:
- Coexisting diabetes and hypertension significantly increase the risk of premature cardiovascular morbidity and mortality.
- Effective management strategies are essential for this growing patient population.
Purpose of the Study:
- To outline an intensive treatment approach for patients with concurrent diabetes and hypertension.
- To emphasize the importance of controlling blood pressure, hyperglycemia, and dyslipidemia.
Main Methods:
- Careful out-of-the-office blood pressure monitoring and postural hypotension testing.
- Implementation of lifestyle modifications and antihypertensive drug therapy.
- Management of hyperglycemia and dyslipidemia.
Main Results:
- Therapy typically requires two or more antihypertensive drugs to achieve blood pressure below 130/85 mm Hg.
- Integrated management of diabetes and hypertension is necessary for comprehensive care.
Conclusions:
- Despite challenges, intensive treatment can protect patients from the debilitating effects of diabetes and hypertension.
- Aggressive management is key to reducing cardiovascular risks in this high-risk group.
Abstract:
The rapidly growing number of patients with coexisting diabetes and hypertension must be intensively treated to protect them from their very high risk for premature cardiovascular morbidity and mortality. After careful ascertainment of their out-of-the-office blood pressure, and testing for postural hypotension, therapy should consist of both lifestyle modifications and antihypertensive drugs. Usually, two or more such drugs are needed to bring blood pressure below the 130/85 mm Hg level. In addition, control of hyperglycemia and dyslipidemia is usually required. Despite the costs and difficulties of achieving adequate control of these diseases, such patients can be protected from the debilities of diabetes and hypertension.